Cargando…
Targeting Wnt/β-catenin-mediated upregulation of oncogenic NLGN3 suppresses cancer stem cells in glioblastoma
Glioblastoma (GBM) is the most malignant tumor in brain and is highly resistant to therapy. Clinical evidence suggests increased number of cancer stem cells (CSCs) may contribute to the failure of conventional therapies, but the mechanisms associated with acquisition of CSC properties in GBM are not...
Autores principales: | Yun, Eun-Jin, Kim, Donghwi, Kim, Sangwoo, Hsieh, Jer-Tsong, Baek, Seung Tae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344874/ https://www.ncbi.nlm.nih.gov/pubmed/37443071 http://dx.doi.org/10.1038/s41419-023-05967-x |
Ejemplares similares
-
Wnt/β-catenin signaling pathway induces autophagy-mediated temozolomide-resistance in human glioblastoma
por: Yun, Eun-Jin, et al.
Publicado: (2020) -
Stanniocalcin 2 drives malignant transformation of human glioblastoma cells by targeting SNAI2 and Matrix Metalloproteinases
por: Yun, Eun-Jin, et al.
Publicado: (2022) -
Glioblastoma recurrence correlates with NLGN3 levels
por: Liu, Rui, et al.
Publicado: (2018) -
NLGN3 Upregulates Expression of ADAM10 to Promote the Cleavage of NLGN3 via Activating the LYN Pathway in Human Gliomas
por: Dang, Ning-Ning, et al.
Publicado: (2021) -
Upregulated NLGN1 predicts poor survival in colorectal cancer
por: Yu, Qian, et al.
Publicado: (2021)